Literature DB >> 1742916

Renal handling of cisplatin: interactions with organic anions and cations in the dog.

J Klein1, Y Bentur, D Cheung, G Moselhy, G Koren.   

Abstract

Cis-diamminedichloroplatinum (II) (cisplatin CDDP) is an extremely potent chemotherapeutic agent. Its efficacy, however, is hindered by the cumulative dose-dependent nephrotoxicity which can lead to permanent renal impairment. The mechanisms of the renal transport of cisplatin are not clear. As a first step towards understanding the renal handling of cisplatin we studied its renal clearance in dogs, as well as the effects of organic anion and cation administration on cisplatin. Our results document net tubular secretion of cisplatin. Both an organic anion (probenecid) and cations (quinidine, cimetidine, ranitidine) significantly decreased renal clearance of free CDDP without affecting GFR.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1742916

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  10 in total

Review 1.  Uptake carriers and oncology drug safety.

Authors:  Jason A Sprowl; Alex Sparreboom
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

2.  Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.

Authors:  K Hanada; K Odaka; A Kudo; H Ogata
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

Review 3.  Cisplatin nephrotoxicity: a review of the literature.

Authors:  Sandhya Manohar; Nelson Leung
Journal:  J Nephrol       Date:  2017-04-05       Impact factor: 3.902

4.  Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.

Authors:  Ryan M Franke; Ashley M Kosloske; Cynthia S Lancaster; Kelly K Filipski; Chaoxin Hu; Oliver Zolk; Ron H Mathijssen; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2010-07-02       Impact factor: 12.531

5.  Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin.

Authors:  F Courjault; D Leroy; L Coquery; H Toutain
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

Review 6.  Polymorphic transporters and platinum pharmacodynamics.

Authors:  Jason A Sprowl; Rachel A Ness; Alex Sparreboom
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-18       Impact factor: 3.614

7.  Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.

Authors:  Xiaolei Pan; Li Wang; Dirk Gründemann; Douglas H Sweet
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

8.  Cisplatin-induced renal injury is independently mediated by OCT2 and p53.

Authors:  Jason A Sprowl; Cynthia S Lancaster; Navjotsingh Pabla; Edwin Hermann; Ashley M Kosloske; Alice A Gibson; Lie Li; Dorothea Zeeh; Eberhard Schlatter; Laura J Janke; Giuliano Ciarimboli; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2014-06-10       Impact factor: 12.531

9.  Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.

Authors:  S Hu; A F Leblanc; A A Gibson; K W Hong; J Y Kim; L J Janke; L Li; A Vasilyeva; D B Finkelstein; J A Sprowl; D H Sweet; E Schlatter; G Ciarimboli; Jhm Schellens; S D Baker; N Pabla; A Sparreboom
Journal:  Clin Transl Sci       Date:  2017-07-08       Impact factor: 4.689

10.  Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

Authors:  Jason T Anderson; Kevin M Huang; Maryam B Lustberg; Alex Sparreboom; Shuiying Hu
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 7.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.